Bullish
Capgemini Invent collaborated with Johnson & Johnson Innovative Medicine France to structure and enhance its Corporate Social Responsibility (CSR) str...
Bullish
Johnson & Johnson has received European CE Mark approval for its new ETHICON™ 4000 Stapler, an advanced surgical stapler designed for reliable staple ...
Neutral
Monument Capital Management boosted its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 25.1% in the fourth quarter, HoldingsChannel.com report...
Neutral
Rede Wealth LLC grew its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 754.1% in the fourth quarter, HoldingsChannel.com reports...
Neutral
A federal judge in Manhattan rejected Bayer's request for an injunction against Johnson & Johnson regarding alleged false advertising for its prostate...
Neutral
Douglas Lane & Associates LLC boosted its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.9% in the 4th quarter, HoldingsChannel reports. ...
Neutral
Johnson & Johnson's strategic shift to innovative medicine and MedTech, following the Kenvue spinoff, aims to strengthen its position in the U.S. heal...
Bullish
This article discusses the 2026 outlook for healthcare giants Johnson & Johnson and Pfizer, noting increased investor interest in the healthcare secto...